SlideShare a Scribd company logo
CENTER FOR PHYSIOTHERAPY AND REHABILITATION
SCIENCE
JAMIA MILLIA ISLAMIA
Submitted to: Dr. Jamal Moiz
Submitted by: Sumaiya Shams
Mpt (cardio)
SPECIAL CONSIDERATION IN CARDIAC
REHABILITATION PROGRAM FOR
HEART TRANSPLANT PATIENT
Introduction
• Heart transplantation is the treatment of choice for eligible
patients with advanced chronic heart failure resulting in
markedly improved survival, functional status, and quality of
life compared with alternative treatments.
• The Registry of the International Society for Heart and Lung
Transplantation’s 2015 report contained 112,521 heart
transplantations performed worldwide between 1982 and 2013
with 1- and 5-year survival of 82% and 69%, respectively.
• Survival is similar for both patients with and without
circulatory support with an LVAD before transplantation
• The age range of heart transplant recipients is from newborn to
the eighth decade of life. For adults, the average age at
transplant is approximately 54 years and 75% are men.
Approximately 50% of children who receive a transplant are
≤5 years of age. The average age of the donors is
approximately 35 years.
Orthotopic transplantation
Heterotopic transplantation
Graft Dysfunction
• The transplanted heart may fail soon after surgery due to
primary graft dysfunction, pulmonary hypertension, or
hyperacute rejection. Primary graft dysfunction is caused by
ischemia and reperfusion injury related to the transplant
procedure and results in the majority of early mortality .
• Contributing factors include brain death of the donor, ischemic
time, and hypothermia of the donor heart. The incidence is
variable but occurs in at least 5% of patients.
• The pathophysiology includes both increased pulmonary
vascular resistance and systemic inflammation.
Rejection
1. Hyperacute Rejection
2. Acute Cellular Rejection
3. Acute Humoral Rejection
4. Chronic (Cardiac Allograft Vasculopathy) Rejection
Medications
Effects Common Immunosuppressant Drugs and Associated Side
Drug
1. Tacrolimus (Prograf)
2. Sirolimus (Rapamune)
3. Mycophenolate mofetil
(CellCept)
4. Prednisone
5. Cyclosporine (Gengraf,
Neoral, Sandimmune)
6. Azathioprine (Imuran)
Potential Common Side Effects
1. Tremor, headache, diarrhea, hypertension,
nausea,renal dysfunction.
2. Skin irritation, tremor, light-headedness, weight
gain, abdominal pain, diarrhea
3. Diarrhea, leukopenia, sepsis, vomiting,
infection,edema
4. Muscle atrophy/weakness, hypertension, fluid
retention, osteoporosis, aseptic necrosis of bone,
“moon” face appearance, truncal obesity,
increased insulin resistance, cataracts, glaucoma,
mood swings, personality change, insomnia,
peptic ulcer disease
5. Renal dysfunction, tremor, hypertension,
hirsutism, gum hyperplasia, muscle cramps,
acne.
6. Nausea/vomiting, leukopenia, thrombocytopenia,
anemia
Common Non rejection Medical Problems
1. Infection and Malignancy
2. Hypertension
3. Obesity
4. Dyslipidemia
5. Diabetes
6. Chronic Renal Insufficiency
7. Osteoporosis
8. Depression
Psychological Factors
• As the period of convalescence continues, patients must
adjust to the tedium of medical appointments and
procedures. As previously discussed, the
immunosuppressant prednisone may cause mood swings
and personality change.
• The first episode of acute rejection may result in heightened
feelings of anxiety and transient depression. As the recovery
from surgery progresses and the degree of medical
surveillance decreases, patients generally shift their
attention from transplant-related activities to becoming
more independent, resuming family roles, and occupational
and avocational pursuits.
• The readjustment to life after transplantation requires
months, and the 1-year anniversary is an important
milestone in this process. Most patients are able to return to
productive and meaningful lives.
Graded Exercise Testing Considerations:
Pretransplant
• Peak vO2 is a powerful prognostic indicator: Patients with an
aerobic capacity of 14 mL ∙ kg−1 ∙ min−1 (4 METs) or below
experience a markedly reduced 1-year survival, independent of
left ventricular ejection fraction.
• Based on the results of the exercise test, an exercise
prescription may be developed for the patient with the goal of
maintaining or even improving cardiorespiratory fitness while
waiting for a donor organ.
Graded Exercise Testing Considerations:
Posttransplant
• Treadmill or cycle ergometer protocols with continuous exercise (2-
or 3-min stages) or ramp tests may be used. Arm cranking protocols
may also be employed after adequate sternal healing, for a specific
upper extremity fitness evaluation, or an arm cranking exercise
prescription.
• The initial exercise intensity should be approximately 2 METs, with
1–2 MET increments in intensity per stage.
• Continuous multilead ECG monitoring with BP measurement and
Borg RPE for each stage is recommended. For precise determination
of aerobic capacity and the ventilatory anaerobic threshold, direct
measurement of O2 and associated variables is highly desirable.
• The endpoints of the graded exercise test should be maximal effort
(symptomlimited maximum) or standard signs of exertional
intolerance.
Heart Rate and Exercise
• As a result of the loss of parasympathetic innervation of the donor heart
with transplantation, heart rate (HR) at rest is elevated at approximately
95–115 bpm and represents the inherent rate of depolarization of the
sinoatrial node
• With graded exercise, for the majority of patients, the HR typically does
not increase during the first several minutes (delayed increase), followed
by a gradual rise with peak HR slightly lower than normal (approximately
150 bpm) due to sympathetic nervous system denervation.
• Many patients achieve their highest exercise HR during the first few
minutes of recovery from exercise rather than at the point of maximal
exercise intensity. HR may remain near peak values for several minutes
during recovery before gradually returning to resting levels (delayed
decrease).
• The chronotropic reserve (the difference between the maximal and
resting HRs) is less than normal.
• Regulation of HR during exercise is dependent on circulating
catecholamines.
Blood, Intracardiac, and Vascular Pressures
• BP at rest is mildly elevated in heart transplant patients, even
though most patients receive antihypertensive medications.
During exercise, BP generally increases appropriately,
although peak exercise BP is slightly lower than expected for
normal persons.
• Vascular resistance is elevated, and intracardiac and
pulmonary vascular pressures (particularly right-sided
pressures) are elevated.
Left Ventricular Function
• For most heart transplant patients, left ventricular ejection
fraction is normal at rest and during exercise. However, as
mentioned previously, left ventricular diastolic function is
often impaired, as evidenced by an elevated filling pressure for
a given end-diastolic volume.
• This impairment results in a below normal increase in stroke
volume during exercise. The impaired rise in stroke volume,
coupled with the below normal HRR, results in an impaired
exercise cardiac output.
Exercise Cardiac Output
• With the onset of exercise, cardiac output in transplant
recipients with complete cardiac denervation increases due to
augmentation of stroke volume via the Frank-Starling
mechanism. Later, increased HR also contributes to
augmentation of cardiac output .
• The greater increase, relative to controls, in left ventricular
end-diastolic volume index during exercise in transplant
patients that results in an enhanced Frank- Starling effect.
However, at rest and during exercise, the cardiac index is
lower for transplant recipients than for normal persons.
Pulmonary Function and Arterial Oxygenation
• The efficiency of pulmonary ventilation during exercise is below
normal during at least the first several months after transplantation,
illustrated by an elevation in the ratio of minute ventilation to
carbon dioxide production (the ventilatory equivalent for CO2, VE/
CO2).
• This excess ventilation results in a heightened sense of shortness of
breath during exercise. The normal increase in tidal volume during
exercise is blunted, probably as a result of respiratory muscle
weakness, deconditioning, and the effects of corticosteroid
medications. Alveolar gas diffusion impairment is present in
approximately 40% of patients. However, arterial oxygen saturation
at rest and during exercise is normal for most patients.
• A minority of patients with pretransplant diffusion abnormalities
experience mild arterial desaturation (to approximately 90%) with
exercise. Azathioprine may cause anemia in some patients, resulting
in reduced arterial oxygen content.
Oxygen Extraction by Exercising Skeletal Muscle
• Extraction of oxygen from the arterial blood by metabolically
active body tissues, as indicated by the arterial-mixed venous
oxygen difference, is normal at rest after transplantation.
• However, during exercise, the arterial mixed venous oxygen
difference does not increase in a normal manner and reflects
abnormalities with both the delivery of capillary blood to the
exercising skeletal muscle and impairment of the oxidative
capacity of the Muscle.
Oxygen Uptake Kinetics, Peak Exercise VO2
• With the onset of exercise, the rate of increase in O2 (oxygen
uptake kinetics) is slower than normal as a result of both an
impaired rise in cardiac output and a diminished oxidative
capacity of the skeletal muscle (reduced arterial-mixed venous
oxygen difference).
Abnormal Exercise Physiology Findings in
Cardiac Transplant Patients
• Increased resting HR
• Delayed HR increase at onset of exercise
• Blunted maximal HR
• Delayed return of HR to resting level after cessation of exercise
• Reduced HRR
• Increased exercise left ventricular end-diastolic pressure (diastolic dysfunction)
• Increased exercise pulmonary artery pressure, pulmonary capillary wedge pressure, right
atrial pressure
• Increased left ventricular end-systolic and end-diastolic volume indices
• Impaired increase in stroke volume during exercise
• Reduced exercise cardiac output
• Decreased exercise arterial-mixed venous oxygen difference
• Slowed oxygen uptake kinetics during exercise
• Decreased maximal oxygen uptake
• Reduced maximal power output during exercise testing
• Decreased ventilatory anaerobic threshold
• Increased exercise ventilatory equivalents for oxygen and carbon dioxide
Potential additional benefits of regular exercise for transplant
recipients:
• Improved submaximal exercise endurance
• Increased peak treadmill exercise workload or peak cycle power output
• Increased maximal HR
• Decreased exercise HR at the same absolute submaximal workload
• Increased ventilatory (anaerobic) threshold
• Decreased submaximal exercise minute ventilation
• Reduced exercise ventilatory equivalent for CO2
• Lessened symptoms of fatigue and/or dyspnea
• Reduced rest and submaximal exercise systolic and diastolic BP
• Decreased peak exercise diastolic BP
• Reduced submaximal exercise RPEs
• Improved psychosocial function
• Increased lean body mass
• Reduced body fat mass
• Increased bone mineral content
Resistance Exercise
• Most cardiac transplant patients require prednisone, at least during
the first several months after surgery, for immunosuppression.
Skeletal muscle atrophy and weakness are common side effects
related to prednisone use.
• Resistance exercise training partially reverses corticosteroid-related
myopathy and improves skeletal muscle strength.
• Horber and associates found definite evidence of skeletal muscle
wasting and weakness in the lower extremities of renal transplant
patients who received prednisone.
• Fifty days of isokinetic strength training substantially increased
muscle mass and strength in these patients.
• In addition, strength training has been shown to improve bone
density and to reduce the potential development of osteoporosis
(also caused by prednisone) in cardiac transplant recipients.
Effect of Exercise Training on Immune Function and
Longevity
• An obvious and important question concerning exercise
training in immunosuppressed cardiac transplant recipients is
the effects of training on immune function.
• Traditional, moderate-intensity training does not increase or
decrease the number or severity of episodes of acute rejection.
In addition, training does not require changes in
immunosuppressant dosage or treatment.
• Infection risk is not changed by exercise training.
Early Mobilization and Inpatient Exercise Training
• Passive range-of-motion exercises for both the upper and lower
extremities, sitting up in a chair, and slow ambulation may begin
and progress gradually after extubation .
• Walking or cycle ergometry may be increased in duration to 20–30
minutes as tolerated. Exercise intensity is guided using the Borg
RPE scale ratings of 11–13 keeping the respiratory rate below 30
breaths per minute and arterial oxygen saturation above 90%.
Exercise frequency is two to three sessions per day.
• Patients whose postoperative courses are uncomplicated typically
remain hospitalized for 7–10 days.
• During inpatient rehabilitation, as well as during the outpatient
phases, episodes of acute rejection of a moderate or greater severity
may require alteration of the exercise plan depending on the
preferences of the transplant team.
• In general, if the rejection episode is graded as moderate, activity
may be continued at the current level but should not progress until
after the rejection has been adequately treated. Severe acute
rejection necessitates suspension of all physical activity with the
exception of passive range-of motion exercises.
Outpatient Exercise Training
• Exercise prescription for cardiac transplant patients is similar
to methods used with patients who have undergone coronary
bypass, coronary valve, or other cardiothoracic surgery. The
one exception is that a target HR is not used, unless the patient
exhibits a partially normalized HR response to exercise as
discussed previously.
• The typical denervated heart increases in rate slowly during
submaximal exercise, and the HR may either drift gradually
higher during steady-state exercise or plateau after several
minutes Borg RPE scale ratings of 12–14 (“somewhat hard”)
may be used to prescribe exercise intensity.
• The HRR (also called chronotropic response), defined as the
difference between the HR at rest and the highest value during
maximal exercise, increases during the first 6 weeks after
transplantation in many patients.
• In a subset of patients, the HRR increases further over the next 6–
12 months.
• A more rapid decline in HR from peak exercise to baseline is
observed in some patients at 1–2 years after transplantation.
• Recently, high-intensity interval training (HIIT) has been used in
exercise programs for transplant recipients and is well tolerated
with favorable effects on fitness .
• The exercise prescription should include standard warm-up and
cool-down activities, a gradual increase in aerobic exercise duration
to 30–60 minutes, and a frequency of four to six sessions per week.
• Typical modes of aerobic exercise used during the early outpatient
recovery period include walking outdoors (or in shopping centers,
schools), treadmill walking, cycle ergometry, and stair climbing
• Special emphasis on upper extremity active range-of-motion exercises is
required. At approximately 6 weeks after surgery, when sternal healing is
nearly completed, rowing, arm cranking, combination arm/leg ergometry,
outdoor cycling, hiking, and jogging become additional options, depending
on a patient’s fitness levels. Sports such as tennis and golf may be
performed as early as 6 weeks after surgery if patient fitness is adequate (5
METs or greater) and sternal healing is nearly complete.
Skeletal muscle weakness in cardiac transplant recipients is
very common
and is related to the following factors
1. Skeletal muscle atrophy due to advanced heart failure
2. Pretransplant deconditioning
3. Corticosteroid use posttransplant as part of the
immunosuppressant regimen.
• Muscle strengthening exercises should be incorporated into the exercise
program to counteract these factors.
• For the first 6 weeks after surgery, bilateral arm lifting is restricted to less
than 10 lb to avoid sternal nonunion.
• During this early stage of rehabilitation, light hand weights are an excellent
method of introducing resistance exercise. After at least 6 weeks of healing,
patients may be started on standard weight machines, emphasizing
moderate resistance, 10–20 slow repetitions per set, one to three sets of
exercises for the major muscle groups, with a frequency of two or three
sessions per week
• Elastic band exercises are also another excellent mode of resistance training
for these patients.
• Borg RPE scale of 12–14 to gauge the intensity of lifting. Strength gains of
25%–50% or greater commonly occur after 8 weeks of strength training in
these patients.
• Performance of the strengthening exercises immediately following the
aerobic portion of the exercise prescription (after the cool-down) is
recommended.
FITT RECOMMENDATIONS FOR INDIVIDUALS WITH
HEART TRANSPLANTATION
• Frequency 3–5 d ∙ wk−1
• Intensity Use RPE of 11–14 on a 6–20 scale.
• Time Progressively increase from 15–20 min ∙d−1 up to 30–60 min
∙ d−1
• Type Treadmill or free walking, stationary cycling, and dual-action
stationary bike
• Resistance Slowly increase upper body activities over several
weeks to months from 40% of 1-RM to 70% of 1-RM. Lower body
excises should begin at 50% of 1-RM. 1–2 sets of 10– 15 repetitions
for each exercise Weight machines are best, but dumbbells, elastic
bands, and body weight can be used.
• Flexibility 2–3 d ∙ wk−1 with daily being most effective Stretch to
the point of feeling tightness or slight discomfort. 10–30 s hold for
static stretching 2–4 repetitions of each exercise Static, dynamic,
and/or PNF stretching.
THANK YOU!!
Seminar presentation 30 sept 2020

More Related Content

What's hot

Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
Rajat Jain
 
Anaesthetic considerations in cardiac patients undergoing non
Anaesthetic considerations in cardiac patients undergoing nonAnaesthetic considerations in cardiac patients undergoing non
Anaesthetic considerations in cardiac patients undergoing non
omar143
 
Dr bassey treadmill exercise stress test
Dr bassey treadmill exercise stress testDr bassey treadmill exercise stress test
Dr bassey treadmill exercise stress test
Lord Ceasar
 
Special consideration in cardiac rehabilitation in heart failure patients
Special consideration in cardiac rehabilitation in heart failure patientsSpecial consideration in cardiac rehabilitation in heart failure patients
Special consideration in cardiac rehabilitation in heart failure patients
QuratBenu1
 
Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!Abhijit Nair
 
Ischaemic heart disease & its anaesthetic implications
Ischaemic heart disease & its anaesthetic implicationsIschaemic heart disease & its anaesthetic implications
Ischaemic heart disease & its anaesthetic implicationsSwadheen Rout
 
Phenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejectionPhenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejection
soumyasil
 
Perioperative myocardial infarction ppt
Perioperative myocardial infarction pptPerioperative myocardial infarction ppt
Perioperative myocardial infarction pptYogasundaram Sasikumar
 
Anaesthesia and ihd
Anaesthesia and ihdAnaesthesia and ihd
Anaesthesia and ihd
Mizanur Rahman
 
Athletes heart
Athletes heartAthletes heart
Athletes heart
Srinivas Kinjarapu
 
Athlete's Heart
Athlete's HeartAthlete's Heart
Athlete's Heart
Sydney Cardiology
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
Anwer Ghani
 
Stress test / Treadmill test
Stress test / Treadmill testStress test / Treadmill test
Stress test / Treadmill test
Khairul Nizam
 
Stress Testing
Stress TestingStress Testing
Stress TestingAmit Verma
 
Levosimendan in acs
Levosimendan in acsLevosimendan in acs
Levosimendan in acs
Kunal Mahajan
 
Exercise testing
Exercise testingExercise testing
Exercise testing
Anshu Yadav
 
Dobutamine stress echocardiography
Dobutamine stress echocardiographyDobutamine stress echocardiography
Dobutamine stress echocardiography
Himanshu Rana
 
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
ISCHEMIC CARDIOPATHY
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
MedPeds Hospitalist
 

What's hot (20)

Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
Anaesthetic considerations in cardiac patients undergoing non
Anaesthetic considerations in cardiac patients undergoing nonAnaesthetic considerations in cardiac patients undergoing non
Anaesthetic considerations in cardiac patients undergoing non
 
Dr bassey treadmill exercise stress test
Dr bassey treadmill exercise stress testDr bassey treadmill exercise stress test
Dr bassey treadmill exercise stress test
 
Special consideration in cardiac rehabilitation in heart failure patients
Special consideration in cardiac rehabilitation in heart failure patientsSpecial consideration in cardiac rehabilitation in heart failure patients
Special consideration in cardiac rehabilitation in heart failure patients
 
Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!Cardiac Evaluation Ppt!
Cardiac Evaluation Ppt!
 
Ischaemic heart disease & its anaesthetic implications
Ischaemic heart disease & its anaesthetic implicationsIschaemic heart disease & its anaesthetic implications
Ischaemic heart disease & its anaesthetic implications
 
Phenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejectionPhenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejection
 
Perioperative myocardial infarction ppt
Perioperative myocardial infarction pptPerioperative myocardial infarction ppt
Perioperative myocardial infarction ppt
 
Anaesthesia and ihd
Anaesthesia and ihdAnaesthesia and ihd
Anaesthesia and ihd
 
Athletes heart
Athletes heartAthletes heart
Athletes heart
 
Athlete's Heart
Athlete's HeartAthlete's Heart
Athlete's Heart
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
Stress test / Treadmill test
Stress test / Treadmill testStress test / Treadmill test
Stress test / Treadmill test
 
Stress Testing
Stress TestingStress Testing
Stress Testing
 
Levosimendan in acs
Levosimendan in acsLevosimendan in acs
Levosimendan in acs
 
Anaesthesia for ischemic heart disease
Anaesthesia for ischemic heart diseaseAnaesthesia for ischemic heart disease
Anaesthesia for ischemic heart disease
 
Exercise testing
Exercise testingExercise testing
Exercise testing
 
Dobutamine stress echocardiography
Dobutamine stress echocardiographyDobutamine stress echocardiography
Dobutamine stress echocardiography
 
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
CIRCULAT Study in Chronic Ischemic Heart Disease (20 Pat)
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 

Similar to Seminar presentation 30 sept 2020

Exercise prescription for CVD
Exercise prescription for CVDExercise prescription for CVD
Exercise prescription for CVD
Ashik Dhakal
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
Anjana KS
 
2. exercise prescription for patients with acute coronary syndrome
2. exercise prescription for patients with acute coronary syndrome2. exercise prescription for patients with acute coronary syndrome
2. exercise prescription for patients with acute coronary syndrome
HibaAnis2
 
Tmt Seminary
Tmt SeminaryTmt Seminary
Tmt Seminary
pravinpawal
 
Dr Jeevraj ppt cardiomyopathy
Dr Jeevraj ppt cardiomyopathyDr Jeevraj ppt cardiomyopathy
Dr Jeevraj ppt cardiomyopathy
jeevraj24
 
Exercise Tolerance Test
Exercise Tolerance TestExercise Tolerance Test
Exercise Tolerance Test
Dr.Sayeedur Rumi
 
Exercise ecg
Exercise ecgExercise ecg
Exercise ecg
Suhail Mohamed P T
 
Exercise Training Recommendation for Individual with Chronic Stable Angina an...
Exercise Training Recommendation for Individual with Chronic Stable Angina an...Exercise Training Recommendation for Individual with Chronic Stable Angina an...
Exercise Training Recommendation for Individual with Chronic Stable Angina an...
nihal Ashraf
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
Chetan Ganteppanavar
 
PHYSIOTHERAPY IN MYOCARDIAL INFARCTION
PHYSIOTHERAPY IN MYOCARDIAL INFARCTIONPHYSIOTHERAPY IN MYOCARDIAL INFARCTION
PHYSIOTHERAPY IN MYOCARDIAL INFARCTION
DhwaniSuthar4
 
Exercise electrocardiography
Exercise electrocardiographyExercise electrocardiography
Exercise electrocardiography
Mostafa Abd El Fattah
 
Stressechocardiography
StressechocardiographyStressechocardiography
Stressechocardiography
Senbeta
 
Stress echocardiography
Stress echocardiographyStress echocardiography
Stress echocardiography
Fuad Farooq
 
Cardiac anesthesia board lecture
Cardiac anesthesia board lectureCardiac anesthesia board lecture
Cardiac anesthesia board lecture
Othman Abdulmajeed
 
Heart failure
Heart failure Heart failure
Heart failure
Sagar Masne
 
Heart failure
Heart failureHeart failure
Heart failure
Shankar Patil
 
Congestive Heart FailureAbstractThe primary function of the he.docx
Congestive Heart FailureAbstractThe primary function of the he.docxCongestive Heart FailureAbstractThe primary function of the he.docx
Congestive Heart FailureAbstractThe primary function of the he.docx
maxinesmith73660
 
Cardiac rehabilitation
Cardiac rehabilitationCardiac rehabilitation
Cardiac rehabilitation
mrinal joshi
 
Recent Advances in CCF
Recent Advances in CCFRecent Advances in CCF
Recent Advances in CCF
Dr Ketan Asawalle
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
AneriPatwari
 

Similar to Seminar presentation 30 sept 2020 (20)

Exercise prescription for CVD
Exercise prescription for CVDExercise prescription for CVD
Exercise prescription for CVD
 
CONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptxCONGESTIVE HEART FAILURE.pptx
CONGESTIVE HEART FAILURE.pptx
 
2. exercise prescription for patients with acute coronary syndrome
2. exercise prescription for patients with acute coronary syndrome2. exercise prescription for patients with acute coronary syndrome
2. exercise prescription for patients with acute coronary syndrome
 
Tmt Seminary
Tmt SeminaryTmt Seminary
Tmt Seminary
 
Dr Jeevraj ppt cardiomyopathy
Dr Jeevraj ppt cardiomyopathyDr Jeevraj ppt cardiomyopathy
Dr Jeevraj ppt cardiomyopathy
 
Exercise Tolerance Test
Exercise Tolerance TestExercise Tolerance Test
Exercise Tolerance Test
 
Exercise ecg
Exercise ecgExercise ecg
Exercise ecg
 
Exercise Training Recommendation for Individual with Chronic Stable Angina an...
Exercise Training Recommendation for Individual with Chronic Stable Angina an...Exercise Training Recommendation for Individual with Chronic Stable Angina an...
Exercise Training Recommendation for Individual with Chronic Stable Angina an...
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
 
PHYSIOTHERAPY IN MYOCARDIAL INFARCTION
PHYSIOTHERAPY IN MYOCARDIAL INFARCTIONPHYSIOTHERAPY IN MYOCARDIAL INFARCTION
PHYSIOTHERAPY IN MYOCARDIAL INFARCTION
 
Exercise electrocardiography
Exercise electrocardiographyExercise electrocardiography
Exercise electrocardiography
 
Stressechocardiography
StressechocardiographyStressechocardiography
Stressechocardiography
 
Stress echocardiography
Stress echocardiographyStress echocardiography
Stress echocardiography
 
Cardiac anesthesia board lecture
Cardiac anesthesia board lectureCardiac anesthesia board lecture
Cardiac anesthesia board lecture
 
Heart failure
Heart failure Heart failure
Heart failure
 
Heart failure
Heart failureHeart failure
Heart failure
 
Congestive Heart FailureAbstractThe primary function of the he.docx
Congestive Heart FailureAbstractThe primary function of the he.docxCongestive Heart FailureAbstractThe primary function of the he.docx
Congestive Heart FailureAbstractThe primary function of the he.docx
 
Cardiac rehabilitation
Cardiac rehabilitationCardiac rehabilitation
Cardiac rehabilitation
 
Recent Advances in CCF
Recent Advances in CCFRecent Advances in CCF
Recent Advances in CCF
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 

Recently uploaded

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 

Recently uploaded (20)

micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 

Seminar presentation 30 sept 2020

  • 1. CENTER FOR PHYSIOTHERAPY AND REHABILITATION SCIENCE JAMIA MILLIA ISLAMIA Submitted to: Dr. Jamal Moiz Submitted by: Sumaiya Shams Mpt (cardio)
  • 2. SPECIAL CONSIDERATION IN CARDIAC REHABILITATION PROGRAM FOR HEART TRANSPLANT PATIENT
  • 3. Introduction • Heart transplantation is the treatment of choice for eligible patients with advanced chronic heart failure resulting in markedly improved survival, functional status, and quality of life compared with alternative treatments. • The Registry of the International Society for Heart and Lung Transplantation’s 2015 report contained 112,521 heart transplantations performed worldwide between 1982 and 2013 with 1- and 5-year survival of 82% and 69%, respectively.
  • 4. • Survival is similar for both patients with and without circulatory support with an LVAD before transplantation • The age range of heart transplant recipients is from newborn to the eighth decade of life. For adults, the average age at transplant is approximately 54 years and 75% are men. Approximately 50% of children who receive a transplant are ≤5 years of age. The average age of the donors is approximately 35 years.
  • 7. Graft Dysfunction • The transplanted heart may fail soon after surgery due to primary graft dysfunction, pulmonary hypertension, or hyperacute rejection. Primary graft dysfunction is caused by ischemia and reperfusion injury related to the transplant procedure and results in the majority of early mortality . • Contributing factors include brain death of the donor, ischemic time, and hypothermia of the donor heart. The incidence is variable but occurs in at least 5% of patients. • The pathophysiology includes both increased pulmonary vascular resistance and systemic inflammation.
  • 8. Rejection 1. Hyperacute Rejection 2. Acute Cellular Rejection 3. Acute Humoral Rejection 4. Chronic (Cardiac Allograft Vasculopathy) Rejection
  • 9. Medications Effects Common Immunosuppressant Drugs and Associated Side Drug 1. Tacrolimus (Prograf) 2. Sirolimus (Rapamune) 3. Mycophenolate mofetil (CellCept) 4. Prednisone 5. Cyclosporine (Gengraf, Neoral, Sandimmune) 6. Azathioprine (Imuran) Potential Common Side Effects 1. Tremor, headache, diarrhea, hypertension, nausea,renal dysfunction. 2. Skin irritation, tremor, light-headedness, weight gain, abdominal pain, diarrhea 3. Diarrhea, leukopenia, sepsis, vomiting, infection,edema 4. Muscle atrophy/weakness, hypertension, fluid retention, osteoporosis, aseptic necrosis of bone, “moon” face appearance, truncal obesity, increased insulin resistance, cataracts, glaucoma, mood swings, personality change, insomnia, peptic ulcer disease 5. Renal dysfunction, tremor, hypertension, hirsutism, gum hyperplasia, muscle cramps, acne. 6. Nausea/vomiting, leukopenia, thrombocytopenia, anemia
  • 10. Common Non rejection Medical Problems 1. Infection and Malignancy 2. Hypertension 3. Obesity 4. Dyslipidemia 5. Diabetes 6. Chronic Renal Insufficiency 7. Osteoporosis 8. Depression
  • 11. Psychological Factors • As the period of convalescence continues, patients must adjust to the tedium of medical appointments and procedures. As previously discussed, the immunosuppressant prednisone may cause mood swings and personality change. • The first episode of acute rejection may result in heightened feelings of anxiety and transient depression. As the recovery from surgery progresses and the degree of medical surveillance decreases, patients generally shift their attention from transplant-related activities to becoming more independent, resuming family roles, and occupational and avocational pursuits. • The readjustment to life after transplantation requires months, and the 1-year anniversary is an important milestone in this process. Most patients are able to return to productive and meaningful lives.
  • 12. Graded Exercise Testing Considerations: Pretransplant • Peak vO2 is a powerful prognostic indicator: Patients with an aerobic capacity of 14 mL ∙ kg−1 ∙ min−1 (4 METs) or below experience a markedly reduced 1-year survival, independent of left ventricular ejection fraction. • Based on the results of the exercise test, an exercise prescription may be developed for the patient with the goal of maintaining or even improving cardiorespiratory fitness while waiting for a donor organ.
  • 13. Graded Exercise Testing Considerations: Posttransplant • Treadmill or cycle ergometer protocols with continuous exercise (2- or 3-min stages) or ramp tests may be used. Arm cranking protocols may also be employed after adequate sternal healing, for a specific upper extremity fitness evaluation, or an arm cranking exercise prescription. • The initial exercise intensity should be approximately 2 METs, with 1–2 MET increments in intensity per stage. • Continuous multilead ECG monitoring with BP measurement and Borg RPE for each stage is recommended. For precise determination of aerobic capacity and the ventilatory anaerobic threshold, direct measurement of O2 and associated variables is highly desirable. • The endpoints of the graded exercise test should be maximal effort (symptomlimited maximum) or standard signs of exertional intolerance.
  • 14. Heart Rate and Exercise • As a result of the loss of parasympathetic innervation of the donor heart with transplantation, heart rate (HR) at rest is elevated at approximately 95–115 bpm and represents the inherent rate of depolarization of the sinoatrial node • With graded exercise, for the majority of patients, the HR typically does not increase during the first several minutes (delayed increase), followed by a gradual rise with peak HR slightly lower than normal (approximately 150 bpm) due to sympathetic nervous system denervation. • Many patients achieve their highest exercise HR during the first few minutes of recovery from exercise rather than at the point of maximal exercise intensity. HR may remain near peak values for several minutes during recovery before gradually returning to resting levels (delayed decrease). • The chronotropic reserve (the difference between the maximal and resting HRs) is less than normal. • Regulation of HR during exercise is dependent on circulating catecholamines.
  • 15. Blood, Intracardiac, and Vascular Pressures • BP at rest is mildly elevated in heart transplant patients, even though most patients receive antihypertensive medications. During exercise, BP generally increases appropriately, although peak exercise BP is slightly lower than expected for normal persons. • Vascular resistance is elevated, and intracardiac and pulmonary vascular pressures (particularly right-sided pressures) are elevated.
  • 16. Left Ventricular Function • For most heart transplant patients, left ventricular ejection fraction is normal at rest and during exercise. However, as mentioned previously, left ventricular diastolic function is often impaired, as evidenced by an elevated filling pressure for a given end-diastolic volume. • This impairment results in a below normal increase in stroke volume during exercise. The impaired rise in stroke volume, coupled with the below normal HRR, results in an impaired exercise cardiac output.
  • 17. Exercise Cardiac Output • With the onset of exercise, cardiac output in transplant recipients with complete cardiac denervation increases due to augmentation of stroke volume via the Frank-Starling mechanism. Later, increased HR also contributes to augmentation of cardiac output . • The greater increase, relative to controls, in left ventricular end-diastolic volume index during exercise in transplant patients that results in an enhanced Frank- Starling effect. However, at rest and during exercise, the cardiac index is lower for transplant recipients than for normal persons.
  • 18. Pulmonary Function and Arterial Oxygenation • The efficiency of pulmonary ventilation during exercise is below normal during at least the first several months after transplantation, illustrated by an elevation in the ratio of minute ventilation to carbon dioxide production (the ventilatory equivalent for CO2, VE/ CO2). • This excess ventilation results in a heightened sense of shortness of breath during exercise. The normal increase in tidal volume during exercise is blunted, probably as a result of respiratory muscle weakness, deconditioning, and the effects of corticosteroid medications. Alveolar gas diffusion impairment is present in approximately 40% of patients. However, arterial oxygen saturation at rest and during exercise is normal for most patients. • A minority of patients with pretransplant diffusion abnormalities experience mild arterial desaturation (to approximately 90%) with exercise. Azathioprine may cause anemia in some patients, resulting in reduced arterial oxygen content.
  • 19. Oxygen Extraction by Exercising Skeletal Muscle • Extraction of oxygen from the arterial blood by metabolically active body tissues, as indicated by the arterial-mixed venous oxygen difference, is normal at rest after transplantation. • However, during exercise, the arterial mixed venous oxygen difference does not increase in a normal manner and reflects abnormalities with both the delivery of capillary blood to the exercising skeletal muscle and impairment of the oxidative capacity of the Muscle.
  • 20. Oxygen Uptake Kinetics, Peak Exercise VO2 • With the onset of exercise, the rate of increase in O2 (oxygen uptake kinetics) is slower than normal as a result of both an impaired rise in cardiac output and a diminished oxidative capacity of the skeletal muscle (reduced arterial-mixed venous oxygen difference).
  • 21. Abnormal Exercise Physiology Findings in Cardiac Transplant Patients • Increased resting HR • Delayed HR increase at onset of exercise • Blunted maximal HR • Delayed return of HR to resting level after cessation of exercise • Reduced HRR • Increased exercise left ventricular end-diastolic pressure (diastolic dysfunction) • Increased exercise pulmonary artery pressure, pulmonary capillary wedge pressure, right atrial pressure • Increased left ventricular end-systolic and end-diastolic volume indices • Impaired increase in stroke volume during exercise • Reduced exercise cardiac output • Decreased exercise arterial-mixed venous oxygen difference • Slowed oxygen uptake kinetics during exercise • Decreased maximal oxygen uptake • Reduced maximal power output during exercise testing • Decreased ventilatory anaerobic threshold • Increased exercise ventilatory equivalents for oxygen and carbon dioxide
  • 22. Potential additional benefits of regular exercise for transplant recipients: • Improved submaximal exercise endurance • Increased peak treadmill exercise workload or peak cycle power output • Increased maximal HR • Decreased exercise HR at the same absolute submaximal workload • Increased ventilatory (anaerobic) threshold • Decreased submaximal exercise minute ventilation • Reduced exercise ventilatory equivalent for CO2 • Lessened symptoms of fatigue and/or dyspnea • Reduced rest and submaximal exercise systolic and diastolic BP • Decreased peak exercise diastolic BP • Reduced submaximal exercise RPEs • Improved psychosocial function • Increased lean body mass • Reduced body fat mass • Increased bone mineral content
  • 23. Resistance Exercise • Most cardiac transplant patients require prednisone, at least during the first several months after surgery, for immunosuppression. Skeletal muscle atrophy and weakness are common side effects related to prednisone use. • Resistance exercise training partially reverses corticosteroid-related myopathy and improves skeletal muscle strength. • Horber and associates found definite evidence of skeletal muscle wasting and weakness in the lower extremities of renal transplant patients who received prednisone. • Fifty days of isokinetic strength training substantially increased muscle mass and strength in these patients. • In addition, strength training has been shown to improve bone density and to reduce the potential development of osteoporosis (also caused by prednisone) in cardiac transplant recipients.
  • 24. Effect of Exercise Training on Immune Function and Longevity • An obvious and important question concerning exercise training in immunosuppressed cardiac transplant recipients is the effects of training on immune function. • Traditional, moderate-intensity training does not increase or decrease the number or severity of episodes of acute rejection. In addition, training does not require changes in immunosuppressant dosage or treatment. • Infection risk is not changed by exercise training.
  • 25. Early Mobilization and Inpatient Exercise Training • Passive range-of-motion exercises for both the upper and lower extremities, sitting up in a chair, and slow ambulation may begin and progress gradually after extubation . • Walking or cycle ergometry may be increased in duration to 20–30 minutes as tolerated. Exercise intensity is guided using the Borg RPE scale ratings of 11–13 keeping the respiratory rate below 30 breaths per minute and arterial oxygen saturation above 90%. Exercise frequency is two to three sessions per day. • Patients whose postoperative courses are uncomplicated typically remain hospitalized for 7–10 days. • During inpatient rehabilitation, as well as during the outpatient phases, episodes of acute rejection of a moderate or greater severity may require alteration of the exercise plan depending on the preferences of the transplant team. • In general, if the rejection episode is graded as moderate, activity may be continued at the current level but should not progress until after the rejection has been adequately treated. Severe acute rejection necessitates suspension of all physical activity with the exception of passive range-of motion exercises.
  • 26. Outpatient Exercise Training • Exercise prescription for cardiac transplant patients is similar to methods used with patients who have undergone coronary bypass, coronary valve, or other cardiothoracic surgery. The one exception is that a target HR is not used, unless the patient exhibits a partially normalized HR response to exercise as discussed previously. • The typical denervated heart increases in rate slowly during submaximal exercise, and the HR may either drift gradually higher during steady-state exercise or plateau after several minutes Borg RPE scale ratings of 12–14 (“somewhat hard”) may be used to prescribe exercise intensity.
  • 27. • The HRR (also called chronotropic response), defined as the difference between the HR at rest and the highest value during maximal exercise, increases during the first 6 weeks after transplantation in many patients. • In a subset of patients, the HRR increases further over the next 6– 12 months. • A more rapid decline in HR from peak exercise to baseline is observed in some patients at 1–2 years after transplantation. • Recently, high-intensity interval training (HIIT) has been used in exercise programs for transplant recipients and is well tolerated with favorable effects on fitness . • The exercise prescription should include standard warm-up and cool-down activities, a gradual increase in aerobic exercise duration to 30–60 minutes, and a frequency of four to six sessions per week. • Typical modes of aerobic exercise used during the early outpatient recovery period include walking outdoors (or in shopping centers, schools), treadmill walking, cycle ergometry, and stair climbing
  • 28. • Special emphasis on upper extremity active range-of-motion exercises is required. At approximately 6 weeks after surgery, when sternal healing is nearly completed, rowing, arm cranking, combination arm/leg ergometry, outdoor cycling, hiking, and jogging become additional options, depending on a patient’s fitness levels. Sports such as tennis and golf may be performed as early as 6 weeks after surgery if patient fitness is adequate (5 METs or greater) and sternal healing is nearly complete.
  • 29. Skeletal muscle weakness in cardiac transplant recipients is very common and is related to the following factors 1. Skeletal muscle atrophy due to advanced heart failure 2. Pretransplant deconditioning 3. Corticosteroid use posttransplant as part of the immunosuppressant regimen.
  • 30. • Muscle strengthening exercises should be incorporated into the exercise program to counteract these factors. • For the first 6 weeks after surgery, bilateral arm lifting is restricted to less than 10 lb to avoid sternal nonunion. • During this early stage of rehabilitation, light hand weights are an excellent method of introducing resistance exercise. After at least 6 weeks of healing, patients may be started on standard weight machines, emphasizing moderate resistance, 10–20 slow repetitions per set, one to three sets of exercises for the major muscle groups, with a frequency of two or three sessions per week • Elastic band exercises are also another excellent mode of resistance training for these patients. • Borg RPE scale of 12–14 to gauge the intensity of lifting. Strength gains of 25%–50% or greater commonly occur after 8 weeks of strength training in these patients. • Performance of the strengthening exercises immediately following the aerobic portion of the exercise prescription (after the cool-down) is recommended.
  • 31. FITT RECOMMENDATIONS FOR INDIVIDUALS WITH HEART TRANSPLANTATION • Frequency 3–5 d ∙ wk−1 • Intensity Use RPE of 11–14 on a 6–20 scale. • Time Progressively increase from 15–20 min ∙d−1 up to 30–60 min ∙ d−1 • Type Treadmill or free walking, stationary cycling, and dual-action stationary bike • Resistance Slowly increase upper body activities over several weeks to months from 40% of 1-RM to 70% of 1-RM. Lower body excises should begin at 50% of 1-RM. 1–2 sets of 10– 15 repetitions for each exercise Weight machines are best, but dumbbells, elastic bands, and body weight can be used. • Flexibility 2–3 d ∙ wk−1 with daily being most effective Stretch to the point of feeling tightness or slight discomfort. 10–30 s hold for static stretching 2–4 repetitions of each exercise Static, dynamic, and/or PNF stretching.